The glucagon-like peptide-1 receptor agonist exenatide does not yield improvement in measures of Parkinson disease severity.
The US Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in ...
From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, scientists were able to identify patterns of neurodegeneration and create metrics ...
Fingernail-sized vibrating gadgets, similar to the tiny devices that make your cellphone buzz, could help people with ...
Dec. 18, 2024 — Dancing lowers the depression associated with Parkinson's disease, and the benefits can be seen in multiple ways, a new study ... Nov. 19, 2024 — A recently published study ...
People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.
Supernus Pharmaceuticals has won Food and Drug Administration approval for its Onapgo device to treat patients with Parkinson's disease.
On Thursday, Jan. 30, the "Walking in Memphis" hitmaker posted about his Parkinson's disease diagnosis on Instagram and explained why he is sharing the news years later. "I feel like it's time to ...
Parkinson’s, the P word. It arises unbidden as I walk ... And one day, tremors, shuffling gait, and all, I might see my 90th birthday, attend my grandchildren’s graduations, and even welcome ...
Abstract: As one of the main motor indicators of Parkinson’s disease (PD), postural instability and gait disorder (PIGD) might manifest in various but subtle symptoms at early stage resulting in ...
placebo-controlled study in early-stage MSA patients achieved “statistical significance”, with up to 48% showing slowing of the debilitating disease. MSA is a so-called Parkinsonian disorder, marked ...
Dancing the Blues Away' Seen in Brain Imaging in People With Parkinson's Disease, New Study Finds Dec. 18, 2024 — Dancing lowers the depression associated with Parkinson's disease, and the ...